Laura Lin - Search Results

Year	Number of Results
2004	3
2005	6
2006	5
2007	3
2008	2
2009	3
2010	2
2011	2
2012	1
2013	4
2015	3
2016	4
2017	1
2018	3
2019	2
2020	6
2021	4
2022	5
2023	2
2024	2

1

The chromatin factors SET-26 and HCF-1 oppose the histone deacetylase HDA-1 in longevity and gene regulation in C. elegans.

Emerson FJ, Chiu C, Lin LY, Riedel CG, Zhu M, Lee SS. Emerson FJ, et al. Among authors: lin ly. Nat Commun. 2024 Mar 14;15(1):2320. doi: 10.1038/s41467-024-46510-6. Nat Commun. 2024. PMID: 38485937 Free PMC article.

2

Tyrosine Sulfation at Antibody Light Chain CDR-1 Increases Binding Affinity and Neutralization Potency to Interleukine-4.

D'Antona AM, Lee JM, Zhang M, Friedman C, He T, Mosyak L, Bennett E, Lin L, Silverman M, Cometa F, Meade C, Hageman T, Sousa E, Cohen J, Marquette K, Ferguson D, Zhong X. D'Antona AM, et al. Among authors: lin l. Int J Mol Sci. 2024 Feb 5;25(3):1931. doi: 10.3390/ijms25031931. Int J Mol Sci. 2024. PMID: 38339208 Free PMC article.

3

Exploring Parametric and Mechanistic Differences between Expi293F^TM and ExpiCHO-S^TM Cells for Transient Antibody Production Optimization.

Zhou J, Yan GG, Cluckey D, Meade C, Ruth M, Sorm R, Tam AS, Lim S, Petridis C, Lin L, D'Antona AM, Zhong X. Zhou J, et al. Among authors: lin l. Antibodies (Basel). 2023 Aug 10;12(3):53. doi: 10.3390/antib12030053. Antibodies (Basel). 2023. PMID: 37606437 Free PMC article.

4

The chromatin factors SET-26 and HCF-1 oppose the histone deacetylase HDA-1 in longevity and gene regulation in C. elegans.

Emerson FJ, Chiu C, Lin LY, Riedel CG, Zhu M, Lee SS. Emerson FJ, et al. Among authors: lin ly. bioRxiv [Preprint]. 2023 Mar 23:2023.03.20.531974. doi: 10.1101/2023.03.20.531974. bioRxiv. 2023. PMID: 36993207 Free PMC article. Updated. Preprint.

5

Reduction of therapeutic antibody self-association using yeast-display selections and machine learning.

Makowski EK, Chen H, Lambert M, Bennett EM, Eschmann NS, Zhang Y, Zupancic JM, Desai AA, Smith MD, Lou W, Fernando A, Tully T, Gallo CJ, Lin L, Tessier PM. Makowski EK, et al. Among authors: lin l. MAbs. 2022 Jan-Dec;14(1):2146629. doi: 10.1080/19420862.2022.2146629. MAbs. 2022. PMID: 36433737 Free PMC article.

6

Impacts of fast production of afucosylated antibodies and Fc mutants in ExpiCHO-S™ for enhancing FcγRIIIa binding and NK cell activation.

Zhong X, Schenk J, Sakorafas P, Chamberland J, Tam A, Thomas LM, Yan G, D' Antona AM, Lin L, Nocula-Lugowska M, Zhang Y, Sousa E, Cohen J, Gu L, Abel M, Donahue J, Lim S, Meade C, Zhou J, Riegel L, Birch A, Fennell BJ, Franklin E, Gomes JM, Tzvetkova B, Scarcelli JJ. Zhong X, et al. Among authors: lin l. J Biotechnol. 2022 Dec 10;360:79-91. doi: 10.1016/j.jbiotec.2022.10.016. Epub 2022 Oct 27. J Biotechnol. 2022. PMID: 36341973 Free article.

7

Dephosphorylation of Y228 and Y217 and phosphorylation of Y335 in p120 catenin activate convergent extension during zebrafish gastrulation.

Shan B, Horton EC, Xu SC, Huntington KE, Kawano DK, Mendoza CL, Lin L, Stafford CM, Allen ED, Huang J, Nakahara H, Greenstein LE, Hille MB. Shan B, et al. Among authors: lin l. Dev Dyn. 2022 Dec;251(12):1934-1951. doi: 10.1002/dvdy.524. Epub 2022 Sep 19. Dev Dyn. 2022. PMID: 35996230 Free article.

8

Cysteine metabolic engineering and selective disulfide reduction produce superior antibody-drug-conjugates.

Procopio-Melino R, Kotch FW, Prashad AS, Gomes JM, Wang W, Arve B, Dawdy A, Chen L, Sperry J, Hosselet C, He T, Kriz R, Lin L, Marquette K, Tchistiakova L, Somers W, Rouse JC, Zhong X. Procopio-Melino R, et al. Among authors: lin l. Sci Rep. 2022 May 4;12(1):7262. doi: 10.1038/s41598-022-11344-z. Sci Rep. 2022. PMID: 35508689 Free PMC article.

9

Large-Scale Transient Production in ExpiCHO-S™ with Enhanced N-Galactosylation-Sialylation and PEI-Based Transfection.

Zhong X, Schwab A, Ma W, Meade CL, Zhou J, D'Antona AM, Somers W, Lin L. Zhong X, et al. Among authors: lin l. Methods Mol Biol. 2022;2313:143-150. doi: 10.1007/978-1-0716-1450-1_7. Methods Mol Biol. 2022. PMID: 34478135

10

An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.

Xu Y, Carrascosa LC, Yeung YA, Chu ML, Yang W, Djuretic I, Pappas DC, Zeytounian J, Ge Z, de Ruiter V, Starbeck-Miller GR, Patterson J, Rigas D, Chen SH, Kraynov E, Boor PP, Noordam L, Doukas M, Tsao D, Ijzermans JN, Guo J, Grünhagen DJ, Erdmann J, Verheij J, van Royen ME, Doornebosch PG, Feldman R, Park T, Mahmoudi S, Dorywalska M, Ni I, Chin SM, Mistry T, Mosyak L, Lin L, Ching KA, Lindquist KC, Ji C, Londono LM, Kuang B, Rickert R, Kwekkeboom J, Sprengers D, Huang TH, Chaparro-Riggers J. Xu Y, et al. Among authors: lin l. Cancer Immunol Res. 2021 Oct;9(10):1141-1157. doi: 10.1158/2326-6066.CIR-21-0058. Epub 2021 Aug 10. Cancer Immunol Res. 2021. PMID: 34376502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

56 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year